Final Results of Prospective Treatment with Pegylated Interferon Alfa-2a for Patients with Polycythemia Vera and Essential Thrombocythemia in First and Second-Line Settings

被引：4

作者：

Yacoub, Abdulraheem ^{[1
,2
]}

Mascarenhas, John ^{[3
]}

Mesa, Ruben A. ^{[4
]}

Kosiorek, Heidi E. ^{[5
]}

Rampal, Raajit K. ^{[6
]}

Silver, Richard T. ^{[7
]}

Salama, Mohamed E. ^{[8
]}

Siwoski, Olivia ^{[9
]}

Dueck, Amylou C. ^{[5
]}

Sandy, Lonette ^{[10
]}

McMullin, Mary Frances ^{[11
]}

Ewing, Joanne ^{[12
]}

O'Connell, Casey L. ^{[13
]}

Mead, Adam J. ^{[14
]}

De Stefano, Valerio ^{[15
]}

Weinberg, Rona Singer ^{[16
]}

Baer, Maria R. ^{[17
]}

Kessler, Craig M. ^{[18
]}

Winton, Elliott F. ^{[19
]}

Vannucchi, Alessandro M. ^{[20
,21
]}

Kremyanskaya, Marina ^{[22
]}

Vadakara, Joseph ^{[23
]}

Rosti, Vittorio ^{[24
]}

Hexner, Elizabeth O. ^{[25
]}

Rondelli, Damiano ^{[26
]}

Arcasoy, Murat O. ^{[27
]}

Rambaldi, Alessandro ^{[28
,29
]}

Ritchie, Ellen K. ^{[30
]}

Barbui, Tiziano ^{[31
]}

Kiladjian, Jean-Jacques ^{[32
]}

Harrison, Claire N. ^{[33
]}

Prchal, Josef T. ^{[34
,35
]}

Hoffman, Ronald ^{[3
]}

机构：

[1] Univ Kansas, Dept Hematol Malignancies & Cellular Therapies, Canc Ctr, Westwood, KS USA

[2] Kansas Univ, Malignant Hematol & Cellular Therapuit, Canc Ctr, Leawood, KS USA

[3] Icahn Sch Med Mt Sinai, Div Hematol Med Oncol, Tisch Canc Inst, New York, NY 10029 USA

[4] UT Hlth San Antonio MD Anderson, Mays Canc Ctr, San Antonio, TX USA

[5] Mayo Clin, Dept Biostat, Scottsdale, AZ USA

[6] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[7] NewYork Presbyterian Weill Cornell Med Ctr, Richard T Silver Myeloproliferat Neoplasms Ctr, New York, NY USA

[8] Mayo Med Labs, Rochester, MN USA

[9] Univ Kansas, Malignant Hematol & Cellular Therapuit, Canc Ctr, Westwood, KS USA

[10] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[11] Queens Univ, Belfast, Antrim, North Ireland

[12] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England

[13] Univ Southern Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90007 USA

[14] Univ Oxford, Oxford, England

[15] Univ Cattolica, Fdn Policlin Gemelli IRCCS, Ist Ematol, Rome, Italy

[16] New York Blood Ctr, New York, NY 10021 USA

[17] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA

[18] Georgetown Univ, Med Ctr, Washington, DC 20007 USA

[19] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA

[20] Univ Florence, CRIMM, Florence, Italy

[21] Univ Florence, Ctr Res & Innovat Myeloproliferat Neoplasms, Florence, Italy

[22] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[23] Geisinger Med Ctr, Danville, PA 17822 USA

[24] IRCCS Policlin San Matteo Fdn, Ctr Study Myelofibrosis, Lab Biochem Biotecnol & Adv Diag, Pavia, Italy

[25] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[26] Univ Illinois, Div Hematol Oncol, Chicago, IL USA

[27] Duke Univ, Sch Med, Durham, NC USA

[28] Univ Milan, Bergamo, Italy

[29] Azienda Socio Sanit Terr Papa Giovanni XX, Bergamo, Italy

[30] Weill Cornell Med Coll New York Presbyterian, New York, NY USA

[31] ASST Papa Giovanni XXIII, FROM Res Fdn, Bergamo, Italy

[32] Hop St Louis, Paris, France

[33] Guys & St Thomas NHS Fdn Trust, Dept Clin Haematol, London, England

[34] Univ Utah, Div Hematol, Salt Lake City, UT USA

[35] Huntsman Canc Ctr, Salt Lake City, UT USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-124865

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2943

引用

页数：5

共 50 条

[1] Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Yacoub, Abdulraheem
Mascarenhas, John
Kosiorek, Heidi
Prchal, Josef T.
Berenzon, Dmitry
Baer, Maria R.
Ritchie, Ellen
Silver, Richard T.
Kessler, Craig
Winton, Elliott
Finazzi, Maria Chiara
Rambaldi, Alessandro
Vannucchi, Alessandro M.
Leibowitz, David
Rondelli, Damiano
Arcasoy, Murat O.
Catchatourian, Rosalind
Vadakara, Joseph
Rosti, Vittorio
Hexner, Elizabeth
Kremyanskaya, Marina
Sandy, Lonette
Tripodi, Joseph
Najfeld, Vesna
Farnoud, Noushin
Papaemmanuil, Elli
Salama, Mohamed
Singer-Weinberg, Rona
Rampal, Raajit
Goldberg, Judith D.
Barbui, Tiziano
Mesa, Ruben
Dueck, Amylou C.
Hoffman, Ronald
[J]. BLOOD, 2019, 134 (18) : 1498 - 1509
[2] Pegylated interferon alfa-2a is effective and decreases LDH levels in patients with essential thrombocythemia and polycythemia vera
Ekinci, O.
[J]. LEUKEMIA RESEARCH, 2019, 85 : S27 - S27
[3] A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis
Mascarenhas, J.
Kosiorek, H.
Prchal, J.
Yacoub, A.
Berenzon, D.
Baer, M. R.
Ritchie, E.
Silver, R. T.
Kessler, C.
Winton, E.
Finazzi, M. C.
Rambaldi, A.
Vannucchi, A. M.
Leibowitz, D.
Rondelli, D.
Arcasoy, M. O.
Catchatourian, R.
Vadakara, J.
Rosti, V.
Hexner, E.
Kremyanskaya, M.
Sandy, L.
Tripodi, J.
Najfeld, V.
Farnoud, N.
Salama, M. E.
Weinberg, R. S.
Rampal, R.
Goldberg, J. D.
Mesa, R.
Dueck, A. C.
Hoffman, R.
[J]. LEUKEMIA, 2019, 33 (12) : 2974 - 2978
[4] A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis
J. Mascarenhas
H. Kosiorek
J. Prchal
A. Yacoub
D. Berenzon
M. R. Baer
E. Ritchie
R. T. Silver
C. Kessler
E. Winton
M. C. Finazzi
A. Rambaldi
A. M. Vannucchi
D. Leibowitz
D. Rondelli
M. O. Arcasoy
R. Catchatourian
J. Vadakara
V. Rosti
E. Hexner
M. Kremyanskaya
L. Sandy
J. Tripodi
V. Najfeld
N. Farnoud
M. E. Salama
R. S. Weinberg
R. Rampal
J. D. Goldberg
R. Mesa
A. C. Dueck
R. Hoffman
[J]. Leukemia, 2019, 33 : 2974 - 2978
[5] Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses
Tashi, Tsewang
Swierczek, Sabina
Kim, Soo Jin
Salama, Mohamed E.
Song, Jihyun
Heikal, Nahla
King, Katherine Y.
Hickman, Kim
Litton, Scott
Prchal, Josef T.
[J]. LEUKEMIA, 2018, 32 (08) : 1830 - 1833
[6] Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses
Tsewang Tashi
Sabina Swierczek
Soo Jin Kim
Mohamed E. Salama
Jihyun Song
Nahla Heikal
Katherine Y. King
Kim Hickman
Scott Litton
Josef T. Prchal
[J]. Leukemia, 2018, 32 : 1830 - 1833
[7] Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
Quintas-Cardama, Alfonso
Kantarjian, Hagop
Manshouri, Taghi
Luthra, Rajyalakshmi
Estrov, Zeev
Pierce, Sherry
Richie, Mary Ann
Borthakur, Gautam
Konopleva, Marina
Cortes, Jorge
Verstovsek, Srdan
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (32) : 5418 - 5424
[8] Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia
Kucine, Nicole
Bergmann, Shayla
Krichevsky, Spencer
Jones, Devin
Rytting, Michael
Jain, Juhi
Bennett, Carolyn M.
Resar, Linda M. S.
Mascarenhas, John
Verstovsek, Srdan
Hoffman, Ronald
[J]. PEDIATRIC BLOOD & CANCER, 2021, 68 (03)
[9] Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a
Quintas-Cardama, Alfonso
Abdel-Wahab, Omar
Manshouri, Taghi
Kilpivaara, Outi
Cortes, Jorge
Roupie, Anne-Laure
Zhang, Su-Jiang
Harris, David
Estrov, Zeev
Kantarjian, Hagop
Levine, Ross L.
Verstovsek, Srdan
[J]. BLOOD, 2013, 122 (06) : 893 - 901
[10] Central Histopathology Review of Essential Thrombocythemia and Polycythemia Vera Bone Marrow Biopsies via Digital Tools in a Clinical Trial on Pegylated Interferon Alfa-2a
Zhou, Delu
Pozdnyakova, Olga
Dewar, Rajan
Hasserjian, Robert P.
Etman, Ali
Hoffman, Ronald
Salama, Mohamed E.
[J]. LABORATORY INVESTIGATION, 2016, 96 : 402A - 402A

← 1 2 3 4 5 →